The Department of Defense is seeking quotes for pharmaceutical agents to be considered for its Uniform Formulary, with a focus on specific newly approved drugs to be reviewed at a Pharmacy and Therapeutics Committee meeting in November 2025. A pre-quotation teleconference is scheduled for October 15, 2025. The agency may award blanket purchase and additional discount agreements based on the formulary decisions. The required instructions and response deadlines for clinical questions are contained within the full solicitation documents.